John‐arne Skolbekken
Biographic Data
| ID | 257873 |
|---|---|
| NAME | John‐arne Skolbekken |
| GIVEN NAMES | John‐arne |
| FAMILY NAME | Skolbekken |
| SIGNATURE | SKOLBEKKEN J A |
| AFFILIATIONS | Norwegian University of Science and Technology |
| ORCID | 0000-0002-1924-9207 |
| VERIFIED | Yes |
| TOTAL WORKS | 18 |
| TOTAL CITATIONS | 56 |
| AUTHOR COUNT | 18 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1995 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 2 |
Perspectives on prostate cancer screening with PSA – a focus group study with men in Norway aged 54–85 years
Prostate cancer is the second most commonly diagnosed cancer worldwide, leading the European Commission to suggest prostate cancer screening with prostate specific antigen (PSA) as part of their policy for more and better screening. Screening with PSA is, however, contested due to ambiguous evidence of whether benefits outweigh negative consequences. Treatment may cause incontinence and impotence, potentially threatening masculinity. Learning tha…
Men's sociotechnical imaginaries of artificial intelligence for prostate cancer diagnostics - A focus group study
Artificial intelligence (AI) is increasingly used for diagnostic purposes in cancer care. Prostate cancer is one of the most prevalent cancers affecting men worldwide, but current diagnostic approaches have limitations in terms of specificity and sensitivity. Using AI to interpret MR images in prostate cancer diagnostics shows promising results, but raises questions about implementation, user acceptance, trust, and doctor-patient communication. D…
Valuing good health care: How medical doctors, scientists and patients relate ethical challenges with artificial intelligence decision-making support tools in prostate cancer diagnostics to good healt…
Artificial intelligence (AI) is increasingly used in health care to improve diagnostics and treatment. Decision-making tools intended to help professionals in diagnostic processes are developed in a variety of medical fields. Despite the imagined benefits, AI in health care is contested. Scholars point to ethical and social issues related to the development, implementation, and use of AI in diagnostics. Here, we investigate how three relevant gro…
Taking it to the bank: The ethical management of individual findings arising in secondary research
A rapidly growing proportion of health research uses ‘secondary data’: data used for purposes other than those for which it was originally collected. Do researchers using secondary data have an obligation to disclose individual research findings to participants? While the importance of this question has been duly recognised in the context of primary research (ie, where data are collected from participants directly), it remains largely unexamined …
Scientific Citizenship’s Youngest Domain: Function Creep in Norway’s Newborn Screening Programme
Newborn screening (NBS) for inborn errors of metabolism and other serious conditions with onset during infancy is a widespread public health initiative. Like other screening programmes, it aims to discover and treat a disease before effects manifest themselves. Recently, there have been two prominent changes in NBS: a substantial increase in the number of conditions screened for and growing attention to secondary use of residual newborn blood spo…
«If you give them your little finger, they’ll tear off your entire arm»: Losing trust in biobank research
Why do some people withdraw from biobank studies? To our knowledge, very few studies have been done on the reflections of biobank ex-participants. In this article, we report from such a study. 16 years ago, we did focus group interviews with biobank participants and ex-participants. We found that the two groups interestingly shared worries concerning the risks involved in possible novel uses of their biobank material, even though they drew opposi…
Online risk numbers - helpful, meaningless or simply wrong? Reflections on online risk calculators
Among the instruments offered to citizens via digital media are risk calculators, aiming at identifying individuals at high risk of various diseases. These calculators present us with both epistemological and socioethical challenges. Tracking the history of individual risk models, this article provides an analysis looking into their content, construction, use and functions. Epistemologically, the notion of risk factor epidemiology frames an appro…
Preparing for and communicating uncertainty in cancer genetic counselling sessions in Norway: An interpretative phenomenological analysis
Risk communication is widely recognised as playing an important role in how individuals at risk of familial cancer understand and interpret their genetic status. To date, however, there has been little empirical investigation directed towards understanding how genetic counsellors themselves understand and actually deal with the challenges of communicating uncertainty of being identified with a gene fault in cancer genetic counselling sessions. In…
Women's Experiences With Mammography Screening Through 6 Years of Participation—A Longitudinal Qualitative Study
In this article we explore women's experiences with 6 years of mammography screening. Regular and repeated mammography screening is promoted as an important tool for disease prevention among women worldwide. The purpose of the present study was to explore how continued participation in screening influences how women perceive screening and breast cancer. We carried out focus groups with 24 screening participants in 2003 and 2009. Our analysis high…
Risk categorisation through standard deviations – the challenge of bone density measurements: A focus group study among women attending the Nord-Trøndelag Health Study (Hunt)
Bone density measurements play an important part in the categorisation of osteoporosis as a risk factor in modern medicine. According to the World Health Organization, people are categorised as having osteoporosis when their bone mineral density (BMD) value is 2.5 standard deviation (SD) below the young adult mean value, and as having osteopenia when the value lies between one and 2.5 SDs below the young adult mean value. The categorisation accor…
Mammography screening and trust: The case of interval breast cancer
Experiences of Recall After Mammography Screening—A Qualitative Study
Women participating in biannual mammography screening for 20 years have a cumulative risk of 20% of being recalled. We conducted a prospective qualitative interview study with eight nonsymptomatic women recalled after mammography screening. These women expressed mixed emotions over being recalled. Information about recall rates and breast cancer risk was seen as alarming, and cancer risk estimates were seen by some as high. The short time between…
From Brittle Bones to Standard Deviations: The Historical Development of Osteoporosis in the Late Twentieth Century
At the dawn of the twenty-first century, osteoporosis is described as a major public health problem of pandemic proportions, affecting millions of people, and women in particular, around the globe. This situation is frequently described as a result of an aging population, but it is also a consequence of a substantial transformation of the medical understanding and definition of osteoporosis in the latter half of the twentieth century. In this art…
Brittle bones, pain and fractures - Lay constructions of osteoporosis among Norwegian women attending the Nord-Trøndelag Health Study (Hunt)
Focus Groups in a Medicine-Dominated Field: Compromises or Quality Improvements
Mammography screening has traditionally been viewed as a field for medical research. The medical science discourse, however, is highly quantitative, and its claims for validity somewhat opposed to those of qualitative research. To communicate research in a cross-disciplinary field, it is necessary to adapt one's research to several paradigms. The authors conducted focus group interviews with women due to be screened in a national breast cancer sc…
Not worth the paper it's written on? Informed consent and biobank research in a Norwegian context
In January 2003 the Norwegian Parliament passed the Biobanks Act, regulating biobank research in Norway. There have been strong differences of opinion both in the process of making the law as well as in its first years of implementation. The main controversy relates to what kind of informed consent should be required for biobank research. Central to the controversy over current interpretations of the Biobanks Act is the informed consent given by …
Epidemiology in nursing and health care
The risk epidemic in medical journals
The risk epidemic in medical journals
Men's sociotechnical imaginaries of artificial intelligence for prostate cancer diagnostics - A focus group study
Artificial intelligence (AI) is increasingly used for diagnostic purposes in cancer care. Prostate cancer is one of the most prevalent cancers affecting men worldwide, but current diagnostic approaches have limitations in terms of specificity and sensitivity. Using AI to interpret MR images in prostate cancer diagnostics shows promising results, but raises questions about implementation, user acceptance, trust, and doctor-patient communication. D…
Mammography screening and trust: The case of interval breast cancer
From Brittle Bones to Standard Deviations: The Historical Development of Osteoporosis in the Late Twentieth Century
At the dawn of the twenty-first century, osteoporosis is described as a major public health problem of pandemic proportions, affecting millions of people, and women in particular, around the globe. This situation is frequently described as a result of an aging population, but it is also a consequence of a substantial transformation of the medical understanding and definition of osteoporosis in the latter half of the twentieth century. In this art…
Brittle bones, pain and fractures - Lay constructions of osteoporosis among Norwegian women attending the Nord-Trøndelag Health Study (Hunt)
Focus Groups in a Medicine-Dominated Field: Compromises or Quality Improvements
Mammography screening has traditionally been viewed as a field for medical research. The medical science discourse, however, is highly quantitative, and its claims for validity somewhat opposed to those of qualitative research. To communicate research in a cross-disciplinary field, it is necessary to adapt one's research to several paradigms. The authors conducted focus group interviews with women due to be screened in a national breast cancer sc…
The risk epidemic in medical journals
Epidemiology in nursing and health care
Not worth the paper it's written on? Informed consent and biobank research in a Norwegian context
In January 2003 the Norwegian Parliament passed the Biobanks Act, regulating biobank research in Norway. There have been strong differences of opinion both in the process of making the law as well as in its first years of implementation. The main controversy relates to what kind of informed consent should be required for biobank research. Central to the controversy over current interpretations of the Biobanks Act is the informed consent given by …
Focus Groups in a Medicine-Dominated Field: Compromises or Quality Improvements
Mammography screening has traditionally been viewed as a field for medical research. The medical science discourse, however, is highly quantitative, and its claims for validity somewhat opposed to those of qualitative research. To communicate research in a cross-disciplinary field, it is necessary to adapt one's research to several paradigms. The authors conducted focus group interviews with women due to be screened in a national breast cancer sc…
Brittle bones, pain and fractures - Lay constructions of osteoporosis among Norwegian women attending the Nord-Trøndelag Health Study (Hunt)
Experiences of Recall After Mammography Screening—A Qualitative Study
Women participating in biannual mammography screening for 20 years have a cumulative risk of 20% of being recalled. We conducted a prospective qualitative interview study with eight nonsymptomatic women recalled after mammography screening. These women expressed mixed emotions over being recalled. Information about recall rates and breast cancer risk was seen as alarming, and cancer risk estimates were seen by some as high. The short time between…
From Brittle Bones to Standard Deviations: The Historical Development of Osteoporosis in the Late Twentieth Century
At the dawn of the twenty-first century, osteoporosis is described as a major public health problem of pandemic proportions, affecting millions of people, and women in particular, around the globe. This situation is frequently described as a result of an aging population, but it is also a consequence of a substantial transformation of the medical understanding and definition of osteoporosis in the latter half of the twentieth century. In this art…
Risk categorisation through standard deviations – the challenge of bone density measurements: A focus group study among women attending the Nord-Trøndelag Health Study (Hunt)
Bone density measurements play an important part in the categorisation of osteoporosis as a risk factor in modern medicine. According to the World Health Organization, people are categorised as having osteoporosis when their bone mineral density (BMD) value is 2.5 standard deviation (SD) below the young adult mean value, and as having osteopenia when the value lies between one and 2.5 SDs below the young adult mean value. The categorisation accor…
Mammography screening and trust: The case of interval breast cancer
Preparing for and communicating uncertainty in cancer genetic counselling sessions in Norway: An interpretative phenomenological analysis
Risk communication is widely recognised as playing an important role in how individuals at risk of familial cancer understand and interpret their genetic status. To date, however, there has been little empirical investigation directed towards understanding how genetic counsellors themselves understand and actually deal with the challenges of communicating uncertainty of being identified with a gene fault in cancer genetic counselling sessions. In…
Women's Experiences With Mammography Screening Through 6 Years of Participation—A Longitudinal Qualitative Study
In this article we explore women's experiences with 6 years of mammography screening. Regular and repeated mammography screening is promoted as an important tool for disease prevention among women worldwide. The purpose of the present study was to explore how continued participation in screening influences how women perceive screening and breast cancer. We carried out focus groups with 24 screening participants in 2003 and 2009. Our analysis high…
Online risk numbers - helpful, meaningless or simply wrong? Reflections on online risk calculators
Among the instruments offered to citizens via digital media are risk calculators, aiming at identifying individuals at high risk of various diseases. These calculators present us with both epistemological and socioethical challenges. Tracking the history of individual risk models, this article provides an analysis looking into their content, construction, use and functions. Epistemologically, the notion of risk factor epidemiology frames an appro…
«If you give them your little finger, they’ll tear off your entire arm»: Losing trust in biobank research
Why do some people withdraw from biobank studies? To our knowledge, very few studies have been done on the reflections of biobank ex-participants. In this article, we report from such a study. 16 years ago, we did focus group interviews with biobank participants and ex-participants. We found that the two groups interestingly shared worries concerning the risks involved in possible novel uses of their biobank material, even though they drew opposi…
Taking it to the bank: The ethical management of individual findings arising in secondary research
A rapidly growing proportion of health research uses ‘secondary data’: data used for purposes other than those for which it was originally collected. Do researchers using secondary data have an obligation to disclose individual research findings to participants? While the importance of this question has been duly recognised in the context of primary research (ie, where data are collected from participants directly), it remains largely unexamined …
Scientific Citizenship’s Youngest Domain: Function Creep in Norway’s Newborn Screening Programme
Newborn screening (NBS) for inborn errors of metabolism and other serious conditions with onset during infancy is a widespread public health initiative. Like other screening programmes, it aims to discover and treat a disease before effects manifest themselves. Recently, there have been two prominent changes in NBS: a substantial increase in the number of conditions screened for and growing attention to secondary use of residual newborn blood spo…
Men's sociotechnical imaginaries of artificial intelligence for prostate cancer diagnostics - A focus group study
Artificial intelligence (AI) is increasingly used for diagnostic purposes in cancer care. Prostate cancer is one of the most prevalent cancers affecting men worldwide, but current diagnostic approaches have limitations in terms of specificity and sensitivity. Using AI to interpret MR images in prostate cancer diagnostics shows promising results, but raises questions about implementation, user acceptance, trust, and doctor-patient communication. D…
Valuing good health care: How medical doctors, scientists and patients relate ethical challenges with artificial intelligence decision-making support tools in prostate cancer diagnostics to good healt…
Artificial intelligence (AI) is increasingly used in health care to improve diagnostics and treatment. Decision-making tools intended to help professionals in diagnostic processes are developed in a variety of medical fields. Despite the imagined benefits, AI in health care is contested. Scholars point to ethical and social issues related to the development, implementation, and use of AI in diagnostics. Here, we investigate how three relevant gro…
Perspectives on prostate cancer screening with PSA – a focus group study with men in Norway aged 54–85 years
Prostate cancer is the second most commonly diagnosed cancer worldwide, leading the European Commission to suggest prostate cancer screening with prostate specific antigen (PSA) as part of their policy for more and better screening. Screening with PSA is, however, contested due to ambiguous evidence of whether benefits outweigh negative consequences. Treatment may cause incontinence and impotence, potentially threatening masculinity. Learning tha…
Medicine (17 works) · Psychology (11 works) · Sociology (9 works) · Political science (8 works) · Ethics in Clinical Research (7 works) · Family medicine (7 works) · Computer Science (6 works) · Focus group (6 works) · Law (6 works) · Pathology (6 works)